Article
Cancer-associated TERT promoter mutations abrogate telomerase silencing.
eLife - 21 Jul 2015
Chiba Kunitoshi, Johnson Joshua Z, Vogan Jacob M, Wagner Tina, Boyle John M, Hockemeyer Dirk
Abstract excerpt
Mutations in the human telomerase reverse transcriptase (TERT) promoter are the most frequent non-coding mutations in cancer, but their molecular mechanism in tumorigenesis has not been established. We used genome editing of human pluripotent stem cells with physiological telomerase expression to elucidate the mechanism by which these mutations contribute to human disease. Surprisingly, telomerase-expressing...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
